Illumina buys rival Pacific Biosciences for $1.2bn
02-11-2018
Vchal / Shutterstock.com
Gene-sequencing companies Illumina and Pacific Biosciences (PacBio) have “mutually agreed” to terminate their $1.2 million merger agreement, under which Illumina would have acquired PacBio.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Illumina, Pacific Biosciences, mergers and acquisitons, M&A, genetics, gene sequencing
